Compare Globus Medical Inc. Class A Common Stock (GMED) vs Riot Platforms Inc (RIOT) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

RIOT Platforms trades at $16.67, up 1.21% with a bearish technical signal despite bullish oscillators. The company reported significant losses with a net income margin of -196.28% and negative cash flow from operations of -$573 million in 2025. Recent strategic shift to data center leasing secured $9.8 billion in contracted revenue through 2048, attracting major tenants like AMD.

Analyst consensus remains strongly bullish with 94.74% buy ratings and a $31.64 price target, suggesting substantial upside potential. Key risks include persistent negative profitability, high valuation multiples, and execution challenges in the AI infrastructure transition. The stock faces near-term pressure from consecutive earnings misses but offers long-term growth potential through its power capacity assets.